Sequent Medical (Aliso Viejo, California) said that the FDA has approved the inclusion of the SL ("Single Layer") family of WEB Aneurysm Embolization Device devices for use in its U.S. Investigational Device Exemption clinical study called WEB-IT. The firm originally gained FDA approval to go ahead with the trial in August of last year. Read More
